About: Treatment of mild and moderate type-2 diabetes: open prospective trial with Hintonia latiflora extract     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • Background: Extracts from the bark of Hintonia latiflora are used as dietetic measures to support the regulation of glucose metabolism and the stabilization of blood glucose values. Methods: A dry concentrated extract from the bark of Hintonia latiflora in capsule form was tested in an open, prospective clinical study in 41 dietetically stabilized subjects with type 2 diabetes. The effects on parameters of blood glucose control were documented over a period of six months. Results: Fasting and postprandial glucose and the HbA(1c) value declined significantly. In the case of HbA(1c), this meant a reduction of the absolute value from 7.49 +/- 0.72% to 6.82 +/- 0.67% (from 58.4 to 51.0 mmol/mol Hb; intention to treat (ITT) population). Furthermore, cholesterol and triglycerides were slightly reduced and no negative effect on other laboratory parameters and no change of the liver values were observed. Tolerance was very good. In particular, no side effects and no hypoglycemic episodes or worsening of diabetic symptoms occurred. Conclusions: The study confirms the positive effect of extracts from the bark of Hintonia latiflora on blood glucose values suggesting a potential benefit in the management of glucose metabolism in cases of type 2 diabetes.
  • Background: Extracts from the bark of Hintonia latiflora are used as dietetic measures to support the regulation of glucose metabolism and the stabilization of blood glucose values. Methods: A dry concentrated extract from the bark of Hintonia latiflora in capsule form was tested in an open, prospective clinical study in 41 dietetically stabilized subjects with type 2 diabetes. The effects on parameters of blood glucose control were documented over a period of six months. Results: Fasting and postprandial glucose and the HbA(1c) value declined significantly. In the case of HbA(1c), this meant a reduction of the absolute value from 7.49 +/- 0.72% to 6.82 +/- 0.67% (from 58.4 to 51.0 mmol/mol Hb; intention to treat (ITT) population). Furthermore, cholesterol and triglycerides were slightly reduced and no negative effect on other laboratory parameters and no change of the liver values were observed. Tolerance was very good. In particular, no side effects and no hypoglycemic episodes or worsening of diabetic symptoms occurred. Conclusions: The study confirms the positive effect of extracts from the bark of Hintonia latiflora on blood glucose values suggesting a potential benefit in the management of glucose metabolism in cases of type 2 diabetes. (en)
Title
  • Treatment of mild and moderate type-2 diabetes: open prospective trial with Hintonia latiflora extract
  • Treatment of mild and moderate type-2 diabetes: open prospective trial with Hintonia latiflora extract (en)
skos:prefLabel
  • Treatment of mild and moderate type-2 diabetes: open prospective trial with Hintonia latiflora extract
  • Treatment of mild and moderate type-2 diabetes: open prospective trial with Hintonia latiflora extract (en)
skos:notation
  • RIV/00216208:11130/14:10292756!RIV15-MSM-11130___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I
http://linked.open...iv/cisloPeriodika
  • neuveden
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 51153
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11130/14:10292756
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Blood lipids; Liver values; Blood glucose; HbA(1c); Type 2 diabetes; Hintonia latiflora (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • DE - Spolková republika Německo
http://linked.open...ontrolniKodProRIV
  • [B38BCAC0C356]
http://linked.open...i/riv/nazevZdroje
  • European Journal of Medical Research
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 19
http://linked.open...iv/tvurceVysledku
  • Hladíková, Marie
  • Korecova, Marta
http://linked.open...ain/vavai/riv/wos
  • 000334473900001
issn
  • 0949-2321
number of pages
http://bibframe.org/vocab/doi
  • 10.1186/2047-783X-19-16
http://localhost/t...ganizacniJednotka
  • 11130
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 112 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software